In the story of antibacterial medicine, few names linger like sulfonamides. People started using Sulfadimidine as early as the 1930s, after prontosil, another red dye-based sulfa, drew attention for saving lives from bacterial infections. Once lab workers could reliably synthesize sulfa drugs, Sulfadimidine—sometimes called Sulfamethazine—entered the clinical toolkit. It quickly gained recognition because it worked well against common bacterial infections and was easier to make than earlier sulfa drugs. Farmers, veterinarians, and physicians took advantage of its powers. Antibiotics eventually outpaced Sulfadimidine in humans, but for decades, it played a crucial role in keeping both people and animals alive.
Sulfadimidine looks like a fine, white or off-white powder. Its main job is to fight bacterial and protozoal diseases. Today, pharmaceutical companies still produce tablets, powders, suspensions, and injectables using this compound. You still find it in veterinary medicine, where it helps treat pneumonia, colibacillosis, and other stubborn infections. In developing regions, it remains accessible and cost-effective, making a real difference in animal health and, by extension, food security.
Sulfadimidine, called by its chemical name 4-amino-N-(4,6-dimethyl-2-pyrimidinyl) benzenesulfonamide, has a molecular formula of C12H14N4O2S. The powder dissolves modestly in water, much more freely in acetone or dilute acids. It does not break down quickly under normal light or air, so storage tends to be straightforward. Melting point sits around 225°C, a sign of its chemical robustness. From handling in the lab, the powder tends to disperse easily—something that matters for anyone weighing and mixing doses. The compound's low volatility helps keep exposure risks in check.
Any reliable source will specify Sulfadimidine’s purity, which should reach at least 99% for pharmaceutical applications. Impurities like related sulfonamides or breakdown products can impact safety, so reputable producers back up these specs with HPLC and melting point data. Labels need to highlight storage conditions, the batch number, and clear directions on expiration. In veterinary use, clear withdrawal times for food-producing animals protect the public from drug residues in meat or milk.
Manufacturing Sulfadimidine typically starts with acetylation of p-aminobenzenesulfonamide, followed by condensation with 4,6-dimethyl-2-chloropyrimidine. This process demands careful control of temperature and pH to limit byproducts. Crystallization then separates the pure product. The steps aren’t just chemical trivia; every variable, from the solvent choice to the order of mixing, matters for purity and yield. Small variations can cause headaches, such as stubborn impurities or sticky clumps that clog equipment.
Chemists can tweak Sulfadimidine to explore new therapeutic avenues. The sulfonamide group, joined to the aromatic amine, can take on modifications that shift absorption or target different pathogens. Making prodrugs—where a chemical tweak helps get the medicine into the body, then breaks down to release the active form—sometimes improves uptake or reduces side effects. Research on these modifications comes from both established labs and new startups aiming to fight old foes like resistance.
This compound turns up in literature and on labels as Sulfamethazine, Sulfadimidinum, and by trade names like Sulfadimer, Sulmethazine, and Cibazine. Pharmacopeias worldwide recognize its various monikers, so cross-checking names matters during procurement and regulatory filings.
Safe handling of Sulfadimidine reduces risks for workers and end-users. This means gloves, masks, and well-ventilated spaces when mixing or packing. Companies must follow strict protocols for documentation, training, and equipment maintenance. Overuse in livestock can drive resistance, so regulatory bodies enforce maximum residue limits for food-producing animals. Uncontrolled releases can harm the environment, prompting the need for closed-loop systems and responsible waste disposal.
Veterinarians lean on Sulfadimidine for respiratory, gastrointestinal, and urinary infections in cattle, pigs, poultry, and small ruminants. Farmers often value fast recovery and economic price, especially in settings where newer antibiotics are out of reach. In some countries, regulators restrict its use in meat and milk animals to curb drug residues. Developing nations, struggling with outbreaks and tight budgets, find Sulfadimidine indispensable. Some older human medicines, especially for toxoplasmosis or nocardiosis, still include it when better options run thin.
Innovation hasn’t left Sulfadimidine behind. Researchers push into new delivery systems—like tailored-release boluses—or blend it with other drugs for combo therapies that block resistant strains. Surveillance teams watch for resistance patterns, adjusting advice to reduce misuse. Analytical chemists work on faster tests for measuring residues in food, helping regulators act quickly. International agencies keep funding studies to see how it fares in livestock versus newer drugs, not just in a petri dish but out on real farms.
Like all sulfonamides, Sulfadimidine can trigger allergic reactions, especially in people with sulfa sensitivity—rashes, fever, and in rare cases, severe skin reactions. Kidney stones or blood disorders sometimes surface during long treatments. In animals, overdosing leads to poor weight gain or worse. Studies on laboratory rats laid the groundwork for these precautions years ago. Researchers still run experiments to judge acute and chronic toxicity, genotoxicity, and environmental effects. These findings feed directly into labeling and recommendations for dose and duration.
The story of Sulfadimidine doesn’t stop with new drugs and digital diagnostics. Increasing demand for protein and the spread of old infections make its role in animal health as important as ever, especially in low-to-middle income regions. Scientists hope smarter use—dosing only when tests confirm infection, rotating with other drugs, improving farm hygiene—will keep this drug working for years. Think tanks and food safety authorities keep calling for tighter rules, better surveillance networks, and public education. The hope is to secure food safety without losing the very tools that made progress possible in the first place.
Sulfadimidine, sometimes called sulfamethazine, belongs to the family of sulfonamide antibiotics. In the real world, most folks are likely to hear about it in veterinary settings. Vets often use it to help clear up infections in animals. I’ve seen farmers rely on it for their herds, hoping to keep everything from respiratory infections to digestive upsets in check. The drug fights bacteria by blocking folic acid creation, which those bacteria need to grow and multiply. Unlike newer antibiotics, this isn’t a last-resort drug — it’s often part of a practical, first-line approach, especially on smaller farms or in places with fewer resources.
People might not give it much thought, but healthy livestock matter for a lot more than just farm profits. Sick animals can’t grow properly, they don’t produce as much milk, eggs, or meat, and they’re more likely to spread disease to others around them. In rural towns, animal health can mean the difference between enough food on the table and not quite getting by. In my own experience working with people in agriculture, losing even a few head of livestock to infection affects not only income, but entire communities that rely on those animals. Sulfadimidine gives these communities a tool to help prevent bigger outbreaks when one animal starts showing signs of illness.
Using any antibiotic comes with trade-offs. Sulfadimidine, for all its benefits, brings up some big questions about human health. People sometimes worry that using it too much in livestock feeds the problem of antimicrobial resistance. In plain language, if bacteria get used to fighting off sulfadimidine, the drug loses punch over time. This is how drug-resistant bugs can develop, making future infections much tougher to treat. I’ve heard concerns from food safety experts who care about residues, too. After treatment, traces of the drug can show up in milk, meat, or eggs if farmers don’t follow the waiting periods before those products go to market. This isn’t just a regulatory issue — it directly connects to consumer trust in the food they’re buying.
The good news is people have options for managing these risks. Responsible use always starts with solid diagnostics. Instead of reaching for antibiotics at the first sign of trouble, vets and farmers can check what’s actually causing an infection. If it’s viral, for instance, an antibiotic isn’t going to help, so using it would just drive up resistance for nothing. Education matters here. Farmers who know why resistance happens, and who trust their veterinarians, are more likely to use these drugs only when they really count. Monitoring programs at both farm and national levels also help. Tracking residue levels in food and sharing that data builds confidence in the safety of our supply.
Sulfadimidine shows how a single compound can make a big difference, especially in settings where animals play a huge role in people’s lives. There’s nothing flashy about it. It’s not the newest option, but it stands as proof that older tools still count when used with care and knowledge. Real trust comes from knowing what’s in the food and how it’s produced. Focusing on smart, careful use builds a bridge between farmers, veterinarians, and the rest of us who rely on their work every day.
Doctors have leaned on antibiotics like Sulfadimidine for decades, especially in veterinary medicine and, less often these days, in people dealing with infections. Back in pharmacy school, the story was always: “old but useful” – except side effects kept popping up on case reviews. Chances are, anyone who’s dealt with sulfonamides knows that you have to respect their power, but also their unpredictability in some folks.
Nausea, vomiting, and diarrhea show up often for people taking Sulfadimidine. These are not rare complaints, and in practice, most patients expect a little unease with heavy-duty antibiotics. Sometimes appetite vanishes. What seems like a run-of-the-mill stomach ache can lead to folks skipping doses or abandoning treatment. Doctors mention it, pharmacists warn about it, but many still press ahead because a stubborn infection keeps people searching for relief.
Rashes can range from slightly annoying spots to full-body breakouts. I once watched a friend develop a bright red, itchy rash after just a few doses – the doctor switched him to something else. Allergic reactions don’t give many warnings, and skin eruptions like Stevens-Johnson syndrome, although rare, are medical emergencies anyone working in a hospital dreads to see. Just one photo of that kind of severe reaction in a textbook erases any complacency when dealing with sulfa drugs.
Few people realize that antibiotics like Sulfadimidine can quietly alter blood counts. Doctors sometimes find drops in white blood cells, or even anemia, after prolonged use. Regular blood tests help catch this, especially for folks with ongoing infections that need longer treatment. Long ago, I remember seeing a case where a patient growing weaker on antibiotics turned out to have bone marrow suppression. Stopping the drug reversed the problem.
Dehydration or pre-existing kidney issues raise the risk of kidney stones. Sulfadimidine crystals don’t dissolve easily in urine. That can mean pain, blood in the urine, or changes in the way the kidneys work. Old advice from retired physicians still matters: “Tell them to drink extra water.” That simple step sometimes makes all the difference.
The liver gets involved, too. Some users notice yellowing of the skin or the whites of the eyes, a sign the body isn’t handling the drug well. While most people sidestep these serious issues, anyone using Sulfadimidine long-term benefits from regular liver checks. I recall an older relative appearing tired and yellow after weeks on antibiotics – doctors traced it right back to the medication.
Paying close attention to new symptoms – rashes, fatigue, trouble urinating – helps keep side effects from spiraling. Open conversations between patients and healthcare providers matter. Care teams who check in early and often can spot trouble and switch medications before problems grow serious. Fact sheets help, but real-world stories from the clinic teach the lesson best: nothing replaces hands-on monitoring and two-way communication. With Sulfadimidine, as with all antibiotics, this careful approach protects both health and confidence in care.
Sulfadimidine, often seen in both veterinary clinics and sometimes in medical discussions, falls into the family of sulfonamide antibiotics. Its main job is fighting bacterial infections. Farmers, veterinarians, and even pet owners may eventually face a situation where understanding this drug’s dosing could mean a world of difference in an animal’s health.
Anyone who has cared for livestock or pets will recognize the delicate line between help and harm. Giving too little can waste time and money and let infections win. Too much, though, risks serious side effects: kidney problems, blood disorders, or even death. People might think they can just “eyeball” the dose based on a rough weight guess, but that guesswork has very real consequences. The World Health Organization and veterinary pharmacology texts stress that proper dosage depends on exact animal weight, species, and type of infection. It’s not just about following directions—it’s about responsibility.
In practice, veterinarians most often suggest an initial loading dose followed by regular administration. For instance, a common recommendation for cattle or pigs includes a starting dose of 55 mg per kilogram of body weight, delivered either by mouth or injection, then followed by a maintenance dose of 27.5 mg/kg every 24 hours. Dosing in smaller animals like dogs or cats sometimes falls in a similar range, but careful adjustments based on health conditions and age always apply. Skipping these steps just because it looks complicated isn’t safe.
Some animals face higher risks with sulfonamides. Kidney disease or liver trouble raises the danger of side effects. Pregnant or lactating females often require extra caution, and some breeds—especially dogs—carry genes making them extra sensitive. Not paying attention to these risks can lead to tragic results. That’s why consultation with experienced veterinarians is not just a formality. Over the years, I’ve seen livestock operations nearly lose entire herds after locals “shared” leftover medicine without knowing allergies or underlying conditions.
A big concern in agriculture circles revolves around residues in milk or meat. Sulfadimidine, like most antibiotics, sticks around inside the animal for days after treatment. That lag time—known as the withdrawal period—protects consumers from trace antibiotics in food. Regulators such as the Food and Drug Administration enforce strict waiting times, sometimes up to two weeks, before the animal’s products can reach the market. Skipping this waiting period isn’t just illegal; it puts public health at risk and can lead to severe fines.
From experience, education remains the strongest tool against accidental overdoses and resistance. Clear dosage charts, regular recalibration of animal scales, and simple fact sheets in barns help far more than hoping people remember instructions from a year ago. Digital tools—like SMS reminders for dose timing—have made compliance in remote villages much better in recent years. Government and pharma partners could push harder on outreach, especially in areas where veterinary services run thin.
Doing right by animals and people takes more than quick fixes or secondhand advice. Accurate weighing, listening to professionals, and respecting laws keep both herds and communities healthy.
People turn to medicines like sulfadimidine for treatment of bacterial infections, especially in animals. This drug sits on pharmacy shelves to fight off bugs in livestock, but like any sulfa drug, it brings its own baggage. My own background in public health has shown me that ignoring precaution with antibiotics never ends well—problems pop up far beyond the doctor’s or veterinarian’s office. Understanding real risks matters as much as understanding real benefits, especially since the fallout from misuse travels through food, farms, and people.
Allergies spell trouble with any sulfa-based drug. A single dose can trigger skin rashes, swelling, or even life-threatening reactions in sensitive folks. In clinics, the question about sulfa allergy always comes up before a prescription, and it’s not some formality. Even pets get screened. Too many end up in the emergency room or animal hospital after mishandling this point. Folks who’ve had breathing problems, hives, or sudden rashes after other sulfa drugs should walk right past this option.
Anyone dealing with liver or kidney trouble faces serious risks. Sulfadimidine takes a road through these organs before leaving the body. If they don’t filter well, toxic buildup starts. Real people have landed in hospitals with liver failure or worsening kidney disease because someone skipped this step. Blood disorders like porphyria or severe anemia make things even riskier—sulfadimidine can tip the scales in the wrong direction and spark hemolysis in those with G6PD deficiency. I’ve seen stories of unexpected breakdowns, especially in vulnerable populations, after common antibiotics ended up in the wrong hands.
This kind of antibiotic can clash with plenty of other medicines. Diuretics, methotrexate, and anticoagulants like warfarin show up often on warning lists. Mixing them can boost side effects or push bleeding risk higher. Even vaccines interact poorly—sulfadimidine can reduce the effect of the BCG vaccine for tuberculosis. With farm animals, sulfa drugs get mixed into feed, and cross-interactions rarely get the attention they deserve. Over time, such mistakes don’t stay hidden: milk or meat residues, rising antibiotic resistance, and unexpected illness all point back to these overlooked links.
No one likes to talk about antibiotic resistance until it shows up at the doorstep. Every unnecessary use, every wrong prescription, stirs up resistant bacteria. Farm settings, where sulfadimidine is often used by the batch, amplify this issue. Resistant bacteria, like MRSA or ESBL E. coli, don’t stay put—they show up on cutting boards and in clinics miles away. My work with veterinarians and farmers always circles back to dosage, duration, and whether this drug really fits the case.
The fix starts with strong awareness. Doctors, pharmacists, and veterinarians get nowhere without clear guidelines and proper history-taking before giving out sulfadimidine. Monitoring for allergic history, checking organ function, and running drug interaction screens should become routine, not rare. On the farm, tighter controls limit misuse—prescriptions need tracking, withdrawal times require strict observation, and educational outreach must reach those who handle medicated feed. Solutions like these help avoid the cycle of harm, offering true value from a drug that carries real risks and rewards. People handling sulfadimidine can raise the bar just by asking questions and double-checking backgrounds before the next dose ever goes out.
Caring for pregnant and lactating animals means weighing every decision against the health of both the mother and her young. Sulfadimidine, a widely used sulfonamide antibiotic, helps fight bacterial infections in livestock. Farmers and veterinarians often rely on it because of its effectiveness in treating respiratory and digestive tract infections. Still, questions about its use during pregnancy and lactation persist.
Pregnancy in animals involves more than the animal’s own wellbeing. Every medication introduced can find its way to the fetus or to newborns through the mother’s milk. Animal health guidelines urge caution with sulfonamides like sulfadimidine for precisely this reason. The drug crosses the placental barrier and enters milk, exposing developing animals to antibiotics at a stage where their organs and immune systems are especially vulnerable.
Decisions about animal medication demand trust and accuracy. Decades of veterinary research have flagged up risks here. Studies document cases of fetal toxicity linked to sulfonamide use. Sulfadimidine binds to plasma proteins and, in developing fetuses, may displace bilirubin. If this happens, the risk of neurological damage goes up—a fact well documented in published research.
In farming communities, I’ve heard concerns from breeders who learned the hard way. Calves born to cows treated with sulfonamides show signs of weakness, jaundice, and lower survival rates. These firsthand experiences echo the literature. Trust between breeder and veterinarian often grows deeper after tough seasons marked by avoidable losses.
Veterinarians lean on more than textbooks. They draw from history on the farm. Avoiding sulfadimidine in pregnant and lactating animals stands out as the norm in many practices. Exceptions come up only if there's no other option and infection threatens both mother and young. Even then, strict withdrawal periods rule out residues in milk, and the animals are monitored closely for side effects.
Alternatives have entered the conversation, which lightens the load on farmers needing better options. Today’s antibiotics offer targeted results and cause fewer side effects. In my experience, simple steps like improved hygiene, good nutrition, and early disease detection do more for animal health than reaching for medications as a first step.
Residues in meat and milk matter as much to farmers as the wider public. Regulations on drug withdrawal highlight a shared responsibility for food safety. Veterinarians track treatments precisely to make sure no residues persist in products winding up at our tables. Trust in food safety grows when producers and animal health experts take proactive steps on drug use, especially with products meant for pregnant and lactating animals.
Relying on evidence, field experience, and a focus on animal wellbeing guides every decision about sulfadimidine—especially where new life enters the picture. The safest path often means pausing, reconsidering, and calling on expert advice rather than risking the unknown.| Names | |
| Preferred IUPAC name | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide |
| Other names |
Sulfamethazine Sulfadimerazine Sulfadimezine Sulfadimidin |
| Pronunciation | /ˌsʌlfəˈdɪmɪdiːn/ |
| Preferred IUPAC name | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide |
| Other names |
Sulfamethazine Sulfadimerazine |
| Pronunciation | /ˌsʌl.fəˈdɪm.ɪˌdiːn/ |
| Identifiers | |
| CAS Number | 57-68-1 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Sulfadimidine** (also known as **sulfamethazine**) is: `CC1=CC=C(C=C1)S(=O)(=O)NC2=NC=NC=C2N` |
| Beilstein Reference | 1718731 |
| ChEBI | CHEBI:9156 |
| ChEMBL | CHEMBL1400 |
| ChemSpider | 1042 |
| DrugBank | DB00334 |
| ECHA InfoCard | ECHA InfoCard: 100.007.657 |
| EC Number | 3.5.4.19 |
| Gmelin Reference | 78655 |
| KEGG | C06587 |
| MeSH | D013437 |
| PubChem CID | 5327 |
| RTECS number | WN6500000 |
| UNII | RKSXZA2983 |
| UN number | UN2811 |
| CAS Number | 68-35-9 |
| 3D model (JSmol) | `3DModel:JSmol:CNc1cc(S(=O)(=O)Nc2ncccn2)ccc1O` |
| Beilstein Reference | 636953 |
| ChEBI | CHEBI:9156 |
| ChEMBL | CHEMBL138 |
| ChemSpider | 23913 |
| DrugBank | DB00259 |
| ECHA InfoCard | 100.011.674 |
| EC Number | 222-346-8 |
| Gmelin Reference | 52770 |
| KEGG | C07684 |
| MeSH | D004600 |
| PubChem CID | 5326 |
| RTECS number | QT1400000 |
| UNII | 7U1EE1UQSO |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C12H14N4O2S |
| Molar mass | 278.32 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.295 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 0.89 |
| Vapor pressure | 8.2 x 10^-8 mmHg |
| Acidity (pKa) | 7.4 |
| Basicity (pKb) | 7.55 |
| Magnetic susceptibility (χ) | -55.0e-6 cm³/mol |
| Refractive index (nD) | 1.68 |
| Dipole moment | 7.61 D |
| Chemical formula | C12H14N4O2S |
| Molar mass | 278.33 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.295 g/cm³ |
| Solubility in water | Very slightly soluble in water |
| log P | 0.89 |
| Vapor pressure | 2.13E-8 mmHg at 25°C |
| Acidity (pKa) | 7.40 |
| Basicity (pKb) | 7.40 |
| Magnetic susceptibility (χ) | -47.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.675 |
| Dipole moment | 4.61 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 267.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -79.4 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3878 kJ mol⁻¹ |
| Std molar entropy (S⦵298) | 210.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -395.8 kJ/mol |
| Pharmacology | |
| ATC code | J01EB03 |
| ATC code | J01EB03 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause allergic skin reaction, suspected of damaging fertility or the unborn child. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H319: Causes serious eye irritation. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: - |
| Flash point | Flash point: 293.2 °C |
| Autoignition temperature | 460 °C |
| Lethal dose or concentration | LD50 oral rat 17 g/kg |
| LD50 (median dose) | LD50: 5200 mg/kg (rat, oral) |
| NIOSH | SW7330000 |
| PEL (Permissible) | PEL (Permissible) for Sulfadimidine: Not established |
| REL (Recommended) | 0.5-1 g/kg |
| IDLH (Immediate danger) | Not Listed |
| Main hazards | Harmful if swallowed. May cause allergic skin reaction. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | Flash point: 230.1 °C |
| Autoignition temperature | 530 °C |
| Lethal dose or concentration | LD50 oral rat 16 g/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 7000 mg/kg |
| NIOSH | WH1400000 |
| PEL (Permissible) | 15 mg/m³ |
| REL (Recommended) | 1,000 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Sulfadiazine Sulfamethoxazole Sulfapyridine Sulfathiazole |
| Related compounds |
Sulfadiazine Sulfapyridine Sulfamethoxazole Sulfadimethoxine |